10-K: Solitron Devices Reports Strong Revenue Growth and Record Backlog, Despite Lower Net Income Driven by Prior Year's Non-Recurring Gains

Sentiment:

Annual Report


Solitron Devices, Inc. announced a 10% increase in net sales and a 62% surge in backlog for fiscal year 2025, primarily driven by the acquisition of Micro Engineering Inc., though net income decreased significantly due to non-recurring gains in the prior fiscal year and identified material weaknesses in internal controls.

Capital raiseOn April 7, 2025, Solitron entered into a Subscription Agreement with CBE LLC to purchase a total of 1,650,000 units of CBE valued at $1,650,000.This investment is part of CBE's $26 million cash investment in CrossingBridge Advisors, LLC, in return for a 25% membership interest.The Company completed the first funding step for $1,237,500 on April 7, 2025.The remaining $412,500 will be funded once the second closing date is provided.

Summary

  • Net sales for the fiscal year ended February 28, 2025, increased by approximately 10% to $14,049,000, up from $12,757,000 in the prior fiscal year, primarily due to the acquisition of Micro Engineering Inc. (MEI).
  • The Company's order backlog surged by approximately 62% to $18,108,000 as of February 28, 2025, compared to $11,207,000 at February 29, 2024, reflecting increased order activity and the MEI acquisition.
  • Net bookings for fiscal year 2025 were approximately 48% more than net sales, indicating strong future revenue potential.
  • Operating income increased to $998,000 in fiscal year 2025 from $934,000 in fiscal year 2024, driven by higher net sales.
  • Net income for fiscal year 2025 was $815,000, a significant decrease from $5,801,000 in fiscal year 2024, primarily due to a non-recurring bargain purchase gain of $2,236,000 and a deferred tax valuation release of $3,024,000 recorded in fiscal year 2024 related to the MEI acquisition.
  • Gross profit increased to $3,992,000 in fiscal year 2025 from $3,807,000 in fiscal year 2024, but the gross profit margin decreased from 30% to 28% of sales.
  • Selling, General & Administrative (SG&A) expenses increased by 4% to $2,994,000, but decreased as a percentage of sales from 23% to 21%.
  • Cash and cash equivalents increased significantly to $4,099,000 at February 28, 2025, from $2,217,000 in the prior year, with working capital also increasing to $8,594,000 from $6,227,000.
  • The Company identified material weaknesses in its internal control over financial reporting as of February 28, 2025, specifically regarding journal entry review and approval, and segregation of duties.
  • Carolyn Campbell was appointed Chief Financial Officer on September 16, 2024.
  • The Company made a new investment of $1,237,500 in CBE LLC on April 7, 2025, as part of CBE's larger investment in CrossingBridge Advisors, LLC.

Sentiment

Score: 6

Explanation: The company shows strong growth in key operational metrics like revenue, operating income, and backlog, indicating a healthy core business and future prospects. However, the significant drop in reported net income (due to non-recurring items in the prior year) and the identified material weaknesses in internal controls introduce notable caution. The strategic acquisition and new investment are positive long-term signals, but the internal control issues are a near-term concern.

Positives

  • Net sales increased by 10% to $14,049,000 in fiscal year 2025, demonstrating revenue growth.
  • The Company achieved a significant 62% increase in backlog, reaching $18,108,000, indicating strong future demand and order visibility.
  • The book-to-bill ratio of 1.48 to 1 for fiscal year 2025 reflects a substantial increase in new orders compared to sales, suggesting robust business momentum.
  • Operating income grew by 6.85% to $998,000, showing improved operational efficiency before non-operating items.
  • Selling, General & Administrative expenses decreased as a percentage of sales from 23% to 21%, indicating better cost management relative to revenue.
  • Cash and cash equivalents increased by 84.8% to $4,099,000, and working capital increased by 38% to $8,594,000, strengthening the Company's liquidity position.
  • The acquisition of Micro Engineering Inc. (MEI) has contributed to increased sales and gross profit, expanding the Company's market reach into medical electronics.
  • Management has implemented remediation measures for the identified internal control weaknesses, indicating a commitment to improving financial reporting processes.
  • The Company's continued maintenance of MIL-PRF-19500, MIL-PRF-38534 Class H, and AS9100 certifications enhances its marketability and competitive position in military and aerospace sectors.
  • The new investment in CBE LLC and CrossingBridge Advisors, LLC signals a strategic move to maximize return on cash and potentially diversify investment opportunities.

Negatives

  • Net income significantly decreased to $815,000 in fiscal year 2025 from $5,801,000 in fiscal year 2024, primarily due to the absence of non-recurring bargain purchase gain and deferred tax benefit recorded in the prior year.
  • Gross profit margin decreased from 30% in fiscal year 2024 to 28% in fiscal year 2025, indicating a slight erosion in profitability per sale.
  • The Company identified material weaknesses in its internal control over financial reporting as of February 28, 2025, specifically a failure in the design and operation of controls over journal entry review and approval, and a lack of segregation of duties within the financial reporting function.
  • The Company continues to face substantial customer concentration, with two customers accounting for approximately 69% of net sales in fiscal year 2025, posing a risk if any major customer is lost.
  • Supplier concentration remains a concern, with two suppliers providing 51% of production materials in fiscal year 2025, increasing vulnerability to supply chain disruptions or price increases.
  • Increased interest expense of ($272,000) in fiscal year 2025 compared to ($177,000) in fiscal year 2024, primarily due to the MEI property and building purchase.

Risks

  • Substantial customer concentration, where the loss or reduction of business from significant customers (e.g., ConMed Linvatec, RTX Corporation) could materially and adversely affect revenues, profitability, and cash flow.
  • Complex manufacturing processes may lower yields and reduce revenues, with potential delays in product deliveries or reduced yields due to capacity constraints, facility upgrades, or process technology changes.
  • Inability to obtain qualified supplies of raw materials, parts, and finished components on a timely basis and at a cost-effective price, exacerbated by diminishing sources and price volatility of materials like silicon wafers and precious metals.
  • Increased international tariffs and threats of additional tariffs, particularly from countries like Malaysia and China (which supplied 39% and 5% of materials respectively in FY25), could materially and adversely affect business and results of operations by increasing production costs.
  • Inability to successfully execute the acquisition strategy, leading to substantial costs, delays, disruptions, or operational/financial problems during integration, or failure to detect liabilities during due diligence.
  • Continued inflationary pressures could lead to reduced margins and loss of future business if increased operating costs cannot be passed on to customers.
  • Inventories may become obsolete due to short product life cycles or adverse changes in end-market demand, potentially leading to write-downs.
  • Environmental regulations could require significant costs due to handling of hazardous materials and potential liabilities for damages or remediation in case of violations.
  • Highly competitive electronic component industry, characterized by price erosion and rapid technological changes, could reduce gross profit margins.
  • Decline of profitability or other adverse developments in the semiconductor industry, including a general slowdown in demand for military-rated semiconductors.
  • Inability to achieve the intended effects of the business strategy, particularly efforts to increase sales in non-military, scientific, and industrial niche markets, or to offer complementary products to military markets.
  • Inability to introduce new products or the emergence of new technologies that could render existing products obsolete or noncompetitive, especially given limited recent R&D spending.
  • Potential product liability risks inherent in manufacturing and marketing high-reliability electronic components for critical applications.
  • Dependence on recruitment and retention of qualified personnel, with failure to attract and retain key engineering, manufacturing, marketing, sales, and management personnel seriously harming the business.
  • Failure to protect proprietary technologies or maintain the right to use certain technologies, as the Company does not have patent protection on all aspects of its technology and relies on trade secrets.
  • Inability to have sufficient capital resources to make necessary investments in manufacturing technology and equipment, which is capital intensive.
  • Substantial investments in plant and equipment may become impaired or obsolete if not efficiently utilized or if technologies change.
  • Risk due to adverse financial condition of one or more customers, potentially leading to uncollectible receivables or reduced sales.
  • International operations expose the Company to material risks, including changes in legislative/regulatory requirements, trade restrictions, transportation delays, economic/political instability, and difficulties in protecting intellectual property rights.
  • Failure to comply with anti-bribery, anti-corruption, anti-money laundering laws, or allegations of such failure, could result in investigations, fines, loss of export privileges, or termination of government contracts.
  • Compliance with regulations regarding the use of 'conflict minerals' could limit supply and increase the cost of certain metals, or lead to disqualification as a supplier.
  • Dependence on government contracts, which are subject to termination, price renegotiations, and regulatory compliance, increasing costs and potentially negatively impacting revenues.
  • Changes in government policy or economic conditions, including shifts in national defense policies, priorities, or a push for Commercial Off The Shelf (COTS) components over high-reliability components.
  • Changes in Defense related programs and priorities, including potential reductions in U.S. government spending due to debt ceiling discussions or shifts towards ESG initiatives.
  • Policies of the recently formed Department of Government Efficiency (DOGE) and Trump administration policies on reducing federal expenditures could negatively impact revenues from government-related customers.
  • Uncertainty from continued conflicts abroad, high inflation, and increased Federal Reserve interest rates, potentially leading to a recessionary economy and adverse impacts on the market for semiconductor components.
  • Security breaches and other disruptions could compromise the integrity of information, leading to liability, operational disruptions, and damage to reputation.
  • Failure to remediate material weaknesses in internal control over financial reporting or identification of future material weaknesses could adversely affect the accuracy and timing of financial reporting and stock price.
  • Natural disasters, like hurricanes, or other adverse events, particularly affecting the two manufacturing facilities in Florida, could result in damage, closures, or impaired production and delivery.

Future Outlook

Solitron Devices plans to continue expanding its sales of commercial semiconductors and power modules, seeking strategic alliance arrangements. This strategy may necessitate investments in finished goods inventory and capital equipment for new product manufacturing. The Company also intends to explore additional transactions, including acquisitions and new product lines, and consider further share repurchases to utilize its net operating loss carryforwards and maximize cash returns. The Company anticipates capital expenditures of approximately $0.3 million for the next twelve months, funded from operations and existing cash reserves. While the Company expects more variability in bookings going forward, it believes its current cash and equivalents will be sufficient to fund operations for the next twelve months.

Management Comments

  • "Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report." Tim Eriksen, CEO
  • "Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report." Tim Eriksen, CEO & Carolyn Campbell, CFO
  • "The increase [in net sales] was primarily attributable to the acquisition of MEI in fiscal 2024." Management's Discussion and Analysis
  • "The increase [in backlog] was due to increased order activity by our customers and the acquisition of MEI." Management's Discussion and Analysis
  • "The decrease in net income was mainly attributable to the bargain purchase gain and release of the Company's deferred tax valuation recorded in fiscal year 2024 as part of the MEI acquisition." Management's Discussion and Analysis
  • "Management estimates this amount [approximately $3,000,000 in cash and equivalents on hand as of April 30, 2025] will be sufficient to fund the Company's operations and working capital requirements for the next twelve months." Management's Discussion and Analysis
  • "The Company believes that engineering standards, manufacturing techniques and product reliability are more important to the successful manufacture and sale of its products than the expired or lapsed patents it held."
  • "Management believes, however, that to the extent the Company's business is targeted at the military and aerospace markets, where there has been virtually no foreign competition, it is subjected to less competition than manufacturers of commercial electronic components."
  • "The Company believes that its primary competitive advantage is its ability to produce high quality products as a result of its years of experience, its sophisticated technologies and its experienced staff."
  • "The Company believes that its ability to produce highly reliable custom hybrids in a short period of time will give it a strategic advantage in attempting to penetrate high-end commercial markets and in selling military products complementary with those currently sold, as doing so would enable the Company to produce products early in design and development cycles."
  • "The Company considers its employee relations to be good."
  • "The Company has implemented remediation measures and we are in the process of identifying any additional appropriate remediation measures. There is the potential that our remediation efforts may not be successful." Management's Report on Internal Control over Financial Reporting
  • "The Company's management believes the foregoing efforts will effectively remediate the material weakness after these controls have operated effectively for a reasonable period of time." Management's Report on Internal Control over Financial Reporting

Industry Context

Solitron Devices operates in the highly specialized and competitive solid-state semiconductor components industry, primarily serving the military and aerospace markets. This segment is characterized by a focus on product reliability, performance, and service rather than solely on price, and has historically seen less foreign competition. However, the industry faces challenges from declining U.S. defense spending on high-reliability components and a shift towards Commercial Off The Shelf (COTS) components by the Department of Defense, which intensifies competition. The Company's acquisition of Micro Engineering Inc. (MEI) signifies a strategic move to diversify into non-military, scientific, and industrial niche markets, such as medical electronics, which aligns with broader industry trends of seeking new revenue streams beyond traditional defense contracts. The industry is also capital-intensive, requiring continuous investment in technology and equipment, and is subject to volatility in raw material prices (e.g., silicon, precious metals) and global economic conditions, including inflation and geopolitical conflicts.

Comparison to Industry Standards

  • The document does not provide specific global benchmarks or comparable companies' project results to assess Solitron's performance against industry standards. It mentions competitors in the military market such as Infineon Technologies, Microsemi Corporation, Anaren, Inc., NEOTech, and Sensitron Semiconductor, but does not offer a detailed comparative analysis of their financial or operational metrics against Solitron's results.
  • The Company's certifications (MIL-PRF-19500, MIL-PRF-38534 Class H, AS9100) are prerequisites for supplying to the U.S. government and prime contractors, indicating adherence to high quality and reliability standards within its niche market, which is a competitive advantage.
  • The shift in the Department of Defense's policy towards COTS components, as noted in the risk factors, suggests a divergence from the Company's traditional high-reliability component focus, potentially impacting its competitive positioning relative to companies specializing in COTS products.

Management Changes

RolePrevious PersonNew PersonEffective DateReason
Chief Financial OfficerTim Eriksen (also CEO)Carolyn CampbellSeptember 16, 2024Appointment of a dedicated CFO, previously held by the CEO.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Internal Control WeaknessesIdentified material weaknesses in the design and operation of controls over the review and approval of journal entries at a sufficient level of precision, and a lack of segregation of duties within the financial reporting function.February 28, 2025These weaknesses could adversely affect the accuracy and timing of financial reporting. Management has implemented remediation measures during Q3 and Q4 FY25 and believes they will be effective after a reasonable operating period.
Board Committee IndependenceThe Board of Directors has determined that all members of the Audit, Compensation, and Nominating Committees (Messrs. Aubrey, Chiste, Gillman, and Pointer) meet the criteria for independence specified in the Nasdaq Rules.OngoingEnsures strong independent oversight of financial reporting, executive compensation, and director nominations.
Code of EthicsThe Company has adopted a Code of Ethics for senior officers, including the principal executive, financial, and controller officers.OngoingPromotes ethical behavior and compliance with Sarbanes-Oxley Act requirements.
Insider Trading PolicyImplemented an Insider Trading Policy prohibiting officers, directors, and employees with access to material nonpublic information from engaging in hedging, pledging, or shoring transactions.OngoingAims to prevent misuse of material nonpublic information and align interests with shareholders.

Legal Proceedings

  • As of February 28, 2025, the Company had no known material current, pending, or threatened litigation.
  • David W. Pointer, Chairman of the Board, was subject to a consent order from the State of Washington Department of Financial Institutions, Securities Division, dated March 12, 2018, relating to alleged breaches of fiduciary duty as an investment advisor, resulting in a $10,000 fine and $2,500 costs.
  • Charles M. Gillman, a director, was subject to an SEC administrative order, dated February 14, 2017, relating to alleged violations of Section 13(d) and 16(a) of the Exchange Act, resulting in a $30,000 civil penalty.

Related Party Transactions

  • The Company purchased $106,000 of die from ES Components during the fiscal year ended February 28, 2025. Mr. Aubrey, a director, is a minority owner, and an immediate family member of Mr. Aubrey is the majority owner of ES Components.
  • The Company purchased $79,000 of die from ES Components during the fiscal year ended February 29, 2024.
  • No sales were made by the Company to ES Components during fiscal years ended February 28, 2025, or February 29, 2024.

Stakeholder Impact

  • Shareholders: Potential for increased value due to strong backlog and revenue growth, but tempered by lower net income (due to non-recurring items) and internal control weaknesses. The new investment in CBE/CrossingBridge could offer diversification and long-term returns.
  • Employees: Stable employment with 47 employees at West Palm Beach and 24 at Apopka facilities. The Company considers employee relations to be good, with no work stoppages or labor organizations.
  • Customers: Increased order activity and backlog suggest strong customer demand. The MEI acquisition expands product offerings, particularly in the medical industry. However, customer concentration remains a risk.
  • Suppliers: Continued reliance on a few key suppliers for a significant portion of production materials, posing a risk of supply chain disruptions or price increases.
  • Creditors: Improved cash and working capital positions enhance the Company's ability to meet short-term obligations. The new mortgage loan for the Apopka facility adds to long-term debt.

Next Steps

  • Continue efforts in selling commercial semiconductors and power modules.
  • Develop appropriate strategic alliance arrangements.
  • Aggressively pursue sales of new and recently manufactured products, potentially requiring investment in finished goods inventory and capital equipment (assembly and test) to replace older generation equipment and support new product manufacturing.
  • Explore certain transactions or actions, including acquisitions, additional product lines, and/or investing a portion of its cash into common stocks or higher yielding debt instruments, to fully utilize current net operating loss carryforwards.
  • Continue to consider additional share repurchases under the Company's stock repurchase program.
  • Complete remediation plan for identified material weaknesses in internal control over financial reporting and ensure controls operate effectively for a reasonable period of time.

Key Dates

DateDescription
2023-09-01Company closed the acquisition of Micro Engineering Inc. (MEI).
2024-02-29Fiscal year end for 2024 financial reporting.
2024-05-21Micro Engineering, Inc. (wholly owned subsidiary) purchased the Micro Property (Apopka, Florida facility) for $1,750,000. Also, the Company entered into a Loan Agreement with Bank of America, N.A. for $1,400,000 for this purchase.
2024-09-16Carolyn Campbell was appointed Chief Financial Officer.
2025-02-28Fiscal year end for 2025 financial reporting.
2025-04-07Solitron entered into a Subscription Agreement with CBE LLC to purchase 1,650,000 units for $1,650,000, completing the first funding step of $1,237,500.
2025-05-21Number of shares of common stock outstanding was 2,082,553.
2025-05-23Date of filing of the Annual Report on Form 10-K.
2027-09-08AS 9100:2016 and ISO 9001:2015 certification reissued and valid until this date.

Recommendation

hold

Keywords

Semiconductor components, Military electronics, Aerospace electronics, Power transistors, Power MOSFETs, Hybrids, Field effect transistors, Custom products, Defense contracts, SEC filing, 10-K, Financial results, Backlog, Acquisition, Micro Engineering Inc., Internal controls, Corporate governance, Risk management, Supply chain, Customer concentration, Manufacturing, Electronic components

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.